For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Goodfellow Gems #59
Goodfellow Gems #59
Wednesday 5 July 2017, 12:22 PM
High dose vitamin D supplementation does not prevent CVD
In this New Zealand randomized clinical trial of 5,108 community participants,1 the cumulative incidence of cardiovascular disease for a median follow
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
1. Scragg R et al. Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study: A Randomized Clinical Trial. JAMA Cardiology. Published online April 5, 2017. http://jamanetwork.com/journals/jamacardiology/article-abstract/2615260